Wound Closure


Wound Closure

Johnson & Johnson started mass production of sterile sutures in 1887, and today Ethicon continues to pioneer advances in wound closure.

Johnson & Johnson started mass production of sterile sutures in 1887, and today Ethicon continues to pioneer advances in wound closure.

Ethicon Logo
STRATAFIX™ Knotless Tissue Control Devices suture illustration.


With significantly more points of fixation than traditional sutures, STRATAFIX Knotless Tissue Control Devices allowed for more consistent tension control over every pass and combined the strengthiii and securityiv of interrupted closure with the speedv of continuous closure.3-7,vi

Triclosan-coated suture illustration.

Plus Antibacterial Sutures

Plus Sutures were associated with a nearly 30%vii reduction in the risk of surgical site infection.8

Plus Antibacterial Sutures have been shown in vitro to inhibit bacterial colonization of the suture for 7 days or more and are effective against the most common organisms associated with SSIsviii: 9-11

  • Staphylococcus aureus 
  • Staphylococcus epidermidis 
  • MRSA 
  • MRSE 
  • Escherichia colivi
  • K pneumoniaevi
DERMABOND™ PRINEO™ illustration


DERMABOND PRINEO Skin Closure System provided a flexible microbial barrier with 98.43% protection in vitro for 72 hours against organisms commonly responsible for SSIs.12,ix,x

DERMABOND PRINEO led to greater overall patient satisfaction compared to skin staples. 13-15,xi

Traditional wound closure techniques involving conventional suture, staples and wound dressings may not be the optimal choice to achieve the primary objective of multi-layer, watertight closure.2

Reducing risk factors and improving healing can be achieved with appropriate surgical technique and postoperative care. You can optimise tissue management through the principles of wound healing: gentle handling of tissues, careful haemostasis, obliteration of dead space,and avoidance of tension.16,17  Appropriate choice of wound dressing should manage wound bioburden, limit cross contamination and promote a wound healing environment. 18

Strength & Security icon

STRATAFIX increased wound-holding security without knots. 6,7,19,vi,xii,xiii

Watertight Closure & Obliteration of Dead Space icon

STRATAFIX provided better watertight closure. 19,vi,xiv,xv

Antibacterial & Microbial Barrier Protection icon

STRATAFIX: the only antibacterial barbed suture.20-23,vi,xvi,xvii

Suture Icon

STRATAFIX: the only barbed suture appropriate for fascia.3,24,vi,xviii,xix

Time icon

STRATAFIX: faster xx, stronger xix, more secure xxi.3,6,7,25,26

strength icon

STRATAFIX Symmetric demonstrated superior tissue holding strength.3,xxii

Let’s work together to reduce infection risk, shorten length of stay and minimise readmissions.   

DERMABOND PRINEO Skin Closure System vs. traditional sutures and staples respectively, were associated with: 

Shorter operating time icon

Close faster with DERMABOND™ PRINEO.27,xxiii,xxiv

Lower SSI rates icon

DERMABOND PRINEO: 98.43% protection. 12,x,xxv

Reduced re-admission icon

DERMABOND PRINEO reduced readmission rates. 28,29, xxvi, xxvii

Reduced LOS icon

DERMABOND PRINEO allows for visibility of the wound.30,31, xxviii, xxix

Lower healthcare resource utilisation

DERMABOND PRINEO: less post-op care.13,xi

Easier patient care

DERMABOND PRINEO increased patient satisfaction.13-15,xi

All Wound Closure Products

Helpful Links  

Hip Arthroplasty

Hip Arthroplasty

Knee Arthroplasty

Knee Arthroplasty

Care4today icon


Ethicon logo

Ethicon Home

Ethicon Customer Support

Ethicon Customer Support